| 发明名称 |
HYPOXIA-INDUCIBLE PROTEIN 2 (HIG2), A NOVEL THERAPEUTIC POTENTIAL TARGET OF RENAL CELL CARCINOMA (RCC) |
| 摘要 |
The present invention provides a method for inhibiting growth of a cancer cell, particularly a renal cell carcinoma, by contacting the cell with a composition composed of an HIG2 siRNA or HIG2 antibody. Methods of diagnosing renal cell cancer are also provided within the present invention. |
| 申请公布号 |
WO2005019475(A3) |
申请公布日期 |
2005.08.11 |
| 申请号 |
WO2004JP12411 |
申请日期 |
2004.08.20 |
| 申请人 |
ONCOTHERAPY SCIENCE, INC.;THE UNIVERSITY OF TOKYO;NAKAMURA, YUSUKE;KATAGIRI, TOYOMASA |
发明人 |
NAKAMURA, YUSUKE;KATAGIRI, TOYOMASA |
| 分类号 |
C12Q1/68 |
主分类号 |
C12Q1/68 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
|
| 地址 |
|
